Tempest Therapeutics, Inc.
TPST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$41,843 | -$29,491 | -$35,709 | -$28,302 |
| Dep. & Amort. | $389 | $381 | $638 | $374 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,303 | $2,546 | $1,561 | $1,105 |
| Change in WC | $1,613 | -$2,677 | $868 | -$613 |
| Other Non-Cash | $1,511 | $1,884 | $1,570 | $1,479 |
| Operating Cash Flow | -$33,027 | -$27,357 | -$31,072 | -$25,957 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$435 | -$170 | -$562 | -$135 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $38 |
| Investing Cash Flow | -$435 | -$170 | -$562 | -$97 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$4,398 | $0 | -$4,739 | $15,000 |
| Stock Issued | $28,591 | $35,602 | $8,861 | $33,425 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $307 | $0 | $7,281 | $10,638 |
| Financing Cash Flow | $24,500 | $35,602 | $11,403 | $59,063 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$8,962 | $8,075 | -$20,231 | $33,009 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $39,673 | $31,598 | $51,829 | $18,820 |
| End Cash | $30,711 | $39,673 | $31,598 | $51,829 |
| Free Cash Flow | -$33,462 | -$27,527 | -$31,634 | -$26,092 |